Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.
Hellemans R, Hazzan M, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet JP, Bayle F, Wissing KM, Noël C, Abramowicz D.
Hellemans R, et al. Among authors: mourad g.
Am J Transplant. 2015 Jul;15(7):1923-32. doi: 10.1111/ajt.13191. Epub 2015 Feb 23.
Am J Transplant. 2015.
PMID: 25707875
Free article.
Clinical Trial.